TSNDF (TerrAscend) Risk Assessment


TSNDF TerrAscend Corp TSNDF
32 GF Score
Price $0.63
GF Value $0.99
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is TerrAscend Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of TerrAscend is: High Risk: High uncertainty.

TerrAscend  (OTCPK:TSNDF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

TerrAscend Risk Assessment Related Terms

TSNDF vs ZTS, UTHR: Risk Assessment Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TerrAscend Risk Assessment vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TerrAscend's Risk Assessment distribution charts can be found below:

* The bar in red indicates where TerrAscend's Risk Assessment falls into.


TSNDF
32GF Score
TerrAscend Corp TSNDF
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TerrAscend (TSNDF) Overvalued in 2026?

Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued. The current stock price of $0.63 is trading 36.4% below its estimated GF Value™ of $0.99. GuruFocus considers TerrAscend to be Possible Value Trap.

Key valuation signals for TSNDF:

  • Risk Assessment:
  • GF Value™: $0.99 vs. price of $0.63 (36.4% below fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the TSNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TerrAscend Business Description

Other Exchanges TED:GermanyTSND:Canada
Address 77 City Centre Drive, Suite 501, East Tower, Mississauga, ON, CAN, L5B 1M5
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
32GF Score

Get the complete analysis for TSNDF

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.63
Price
$0.99
GF Value